nodes	percent_of_prediction	percent_of_DWPC	metapath
Itraconazole—ABCB1—peripheral nervous system neoplasm	0.263	1	CbGaD
Itraconazole—CYP1A1—Tretinoin—peripheral nervous system neoplasm	0.0521	0.0977	CbGbCtD
Itraconazole—CYP1A1—Dacarbazine—peripheral nervous system neoplasm	0.0448	0.084	CbGbCtD
Itraconazole—CYP3A7—Tretinoin—peripheral nervous system neoplasm	0.0417	0.0781	CbGbCtD
Itraconazole—CYP3A7-CYP3A51P—Tretinoin—peripheral nervous system neoplasm	0.0417	0.0781	CbGbCtD
Itraconazole—CYP2B6—Tretinoin—peripheral nervous system neoplasm	0.0397	0.0744	CbGbCtD
Itraconazole—CYP2E1—Dacarbazine—peripheral nervous system neoplasm	0.0346	0.0649	CbGbCtD
Itraconazole—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.0313	0.0586	CbGbCtD
Itraconazole—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0219	0.041	CbGbCtD
Itraconazole—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0219	0.041	CbGbCtD
Itraconazole—CYP3A7—Vincristine—peripheral nervous system neoplasm	0.0191	0.0359	CbGbCtD
Itraconazole—CYP3A7-CYP3A51P—Vincristine—peripheral nervous system neoplasm	0.0191	0.0359	CbGbCtD
Itraconazole—CYP2B6—Cisplatin—peripheral nervous system neoplasm	0.017	0.0319	CbGbCtD
Itraconazole—CYP2E1—Etoposide—peripheral nervous system neoplasm	0.0169	0.0317	CbGbCtD
Itraconazole—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0152	0.0284	CbGbCtD
Itraconazole—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.0144	0.0269	CbGbCtD
Itraconazole—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.0132	0.0247	CbGbCtD
Itraconazole—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0131	0.0246	CbGbCtD
Itraconazole—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0122	0.0229	CbGbCtD
Itraconazole—CYP2B6—Doxorubicin—peripheral nervous system neoplasm	0.0114	0.0214	CbGbCtD
Itraconazole—ABCB1—Vincristine—peripheral nervous system neoplasm	0.00934	0.0175	CbGbCtD
Itraconazole—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.00871	0.0163	CbGbCtD
Itraconazole—ABCB1—Etoposide—peripheral nervous system neoplasm	0.00856	0.0161	CbGbCtD
Itraconazole—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00584	0.0109	CbGbCtD
Itraconazole—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0056	0.0105	CbGbCtD
Itraconazole—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.0055	0.0103	CbGbCtD
Itraconazole—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00513	0.00962	CbGbCtD
Itraconazole—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0035	0.00656	CbGbCtD
Itraconazole—Posaconazole—ABCB1—peripheral nervous system neoplasm	0.00157	0.761	CrCbGaD
Itraconazole—Ketoconazole—ABCB1—peripheral nervous system neoplasm	0.000495	0.239	CrCbGaD
Itraconazole—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	8.35e-05	0.000413	CcSEcCtD
Itraconazole—Neutropenia—Epirubicin—peripheral nervous system neoplasm	8.27e-05	0.000409	CcSEcCtD
Itraconazole—Asthenia—Alitretinoin—peripheral nervous system neoplasm	8.25e-05	0.000408	CcSEcCtD
Itraconazole—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	8.24e-05	0.000408	CcSEcCtD
Itraconazole—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	8.22e-05	0.000407	CcSEcCtD
Itraconazole—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	8.18e-05	0.000405	CcSEcCtD
Itraconazole—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	8.17e-05	0.000404	CcSEcCtD
Itraconazole—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	8.16e-05	0.000404	CcSEcCtD
Itraconazole—Pruritus—Alitretinoin—peripheral nervous system neoplasm	8.13e-05	0.000402	CcSEcCtD
Itraconazole—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	8.07e-05	0.000399	CcSEcCtD
Itraconazole—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	8.07e-05	0.000399	CcSEcCtD
Itraconazole—Paraesthesia—Etoposide—peripheral nervous system neoplasm	8.05e-05	0.000399	CcSEcCtD
Itraconazole—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	8.02e-05	0.000397	CcSEcCtD
Itraconazole—Weight decreased—Epirubicin—peripheral nervous system neoplasm	8e-05	0.000396	CcSEcCtD
Itraconazole—Dyspnoea—Etoposide—peripheral nervous system neoplasm	8e-05	0.000396	CcSEcCtD
Itraconazole—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	7.98e-05	0.000395	CcSEcCtD
Itraconazole—Somnolence—Etoposide—peripheral nervous system neoplasm	7.97e-05	0.000395	CcSEcCtD
Itraconazole—Asthenia—Vincristine—peripheral nervous system neoplasm	7.94e-05	0.000393	CcSEcCtD
Itraconazole—Pneumonia—Epirubicin—peripheral nervous system neoplasm	7.93e-05	0.000392	CcSEcCtD
Itraconazole—Infestation—Epirubicin—peripheral nervous system neoplasm	7.88e-05	0.00039	CcSEcCtD
Itraconazole—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	7.88e-05	0.00039	CcSEcCtD
Itraconazole—Drowsiness—Epirubicin—peripheral nervous system neoplasm	7.88e-05	0.00039	CcSEcCtD
Itraconazole—Vomiting—Dactinomycin—peripheral nervous system neoplasm	7.88e-05	0.00039	CcSEcCtD
Itraconazole—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	7.87e-05	0.000389	CcSEcCtD
Itraconazole—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	7.86e-05	0.000389	CcSEcCtD
Itraconazole—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	7.82e-05	0.000387	CcSEcCtD
Itraconazole—Rash—Dactinomycin—peripheral nervous system neoplasm	7.81e-05	0.000387	CcSEcCtD
Itraconazole—Decreased appetite—Etoposide—peripheral nervous system neoplasm	7.8e-05	0.000386	CcSEcCtD
Itraconazole—Renal failure—Epirubicin—peripheral nervous system neoplasm	7.75e-05	0.000383	CcSEcCtD
Itraconazole—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	7.74e-05	0.000383	CcSEcCtD
Itraconazole—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	7.74e-05	0.000383	CcSEcCtD
Itraconazole—Fatigue—Etoposide—peripheral nervous system neoplasm	7.73e-05	0.000383	CcSEcCtD
Itraconazole—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	7.73e-05	0.000382	CcSEcCtD
Itraconazole—Jaundice—Epirubicin—peripheral nervous system neoplasm	7.68e-05	0.00038	CcSEcCtD
Itraconazole—Pain—Etoposide—peripheral nervous system neoplasm	7.67e-05	0.00038	CcSEcCtD
Itraconazole—Constipation—Etoposide—peripheral nervous system neoplasm	7.67e-05	0.00038	CcSEcCtD
Itraconazole—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	7.66e-05	0.000379	CcSEcCtD
Itraconazole—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	7.65e-05	0.000379	CcSEcCtD
Itraconazole—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	7.6e-05	0.000376	CcSEcCtD
Itraconazole—Dizziness—Alitretinoin—peripheral nervous system neoplasm	7.6e-05	0.000376	CcSEcCtD
Itraconazole—Diarrhoea—Vincristine—peripheral nervous system neoplasm	7.58e-05	0.000375	CcSEcCtD
Itraconazole—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	7.56e-05	0.000374	CcSEcCtD
Itraconazole—Haematuria—Epirubicin—peripheral nervous system neoplasm	7.52e-05	0.000372	CcSEcCtD
Itraconazole—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	7.47e-05	0.000369	CcSEcCtD
Itraconazole—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	7.46e-05	0.000369	CcSEcCtD
Itraconazole—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	7.4e-05	0.000366	CcSEcCtD
Itraconazole—Sinusitis—Epirubicin—peripheral nervous system neoplasm	7.4e-05	0.000366	CcSEcCtD
Itraconazole—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	7.39e-05	0.000366	CcSEcCtD
Itraconazole—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	7.38e-05	0.000365	CcSEcCtD
Itraconazole—Nausea—Dactinomycin—peripheral nervous system neoplasm	7.36e-05	0.000364	CcSEcCtD
Itraconazole—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	7.36e-05	0.000364	CcSEcCtD
Itraconazole—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	7.34e-05	0.000363	CcSEcCtD
Itraconazole—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	7.34e-05	0.000363	CcSEcCtD
Itraconazole—Dizziness—Vincristine—peripheral nervous system neoplasm	7.32e-05	0.000362	CcSEcCtD
Itraconazole—Vomiting—Alitretinoin—peripheral nervous system neoplasm	7.31e-05	0.000362	CcSEcCtD
Itraconazole—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	7.29e-05	0.000361	CcSEcCtD
Itraconazole—Infestation—Doxorubicin—peripheral nervous system neoplasm	7.29e-05	0.000361	CcSEcCtD
Itraconazole—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	7.29e-05	0.000361	CcSEcCtD
Itraconazole—Rash—Alitretinoin—peripheral nervous system neoplasm	7.25e-05	0.000358	CcSEcCtD
Itraconazole—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	7.24e-05	0.000358	CcSEcCtD
Itraconazole—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	7.23e-05	0.000358	CcSEcCtD
Itraconazole—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	7.21e-05	0.000357	CcSEcCtD
Itraconazole—Headache—Alitretinoin—peripheral nervous system neoplasm	7.2e-05	0.000356	CcSEcCtD
Itraconazole—Renal failure—Doxorubicin—peripheral nervous system neoplasm	7.17e-05	0.000355	CcSEcCtD
Itraconazole—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	7.15e-05	0.000354	CcSEcCtD
Itraconazole—Urticaria—Etoposide—peripheral nervous system neoplasm	7.13e-05	0.000353	CcSEcCtD
Itraconazole—Jaundice—Doxorubicin—peripheral nervous system neoplasm	7.11e-05	0.000352	CcSEcCtD
Itraconazole—Rhinitis—Epirubicin—peripheral nervous system neoplasm	7.1e-05	0.000351	CcSEcCtD
Itraconazole—Abdominal pain—Etoposide—peripheral nervous system neoplasm	7.09e-05	0.000351	CcSEcCtD
Itraconazole—Body temperature increased—Etoposide—peripheral nervous system neoplasm	7.09e-05	0.000351	CcSEcCtD
Itraconazole—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	7.09e-05	0.000351	CcSEcCtD
Itraconazole—Hepatitis—Epirubicin—peripheral nervous system neoplasm	7.08e-05	0.00035	CcSEcCtD
Itraconazole—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	7.04e-05	0.000348	CcSEcCtD
Itraconazole—Vomiting—Vincristine—peripheral nervous system neoplasm	7.04e-05	0.000348	CcSEcCtD
Itraconazole—Asthenia—Cisplatin—peripheral nervous system neoplasm	7.03e-05	0.000348	CcSEcCtD
Itraconazole—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	7.02e-05	0.000348	CcSEcCtD
Itraconazole—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	6.99e-05	0.000346	CcSEcCtD
Itraconazole—Rash—Vincristine—peripheral nervous system neoplasm	6.98e-05	0.000345	CcSEcCtD
Itraconazole—Dermatitis—Vincristine—peripheral nervous system neoplasm	6.98e-05	0.000345	CcSEcCtD
Itraconazole—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	6.97e-05	0.000345	CcSEcCtD
Itraconazole—Haematuria—Doxorubicin—peripheral nervous system neoplasm	6.96e-05	0.000344	CcSEcCtD
Itraconazole—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	6.95e-05	0.000344	CcSEcCtD
Itraconazole—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	6.94e-05	0.000343	CcSEcCtD
Itraconazole—Headache—Vincristine—peripheral nervous system neoplasm	6.94e-05	0.000343	CcSEcCtD
Itraconazole—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	6.9e-05	0.000341	CcSEcCtD
Itraconazole—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	6.84e-05	0.000339	CcSEcCtD
Itraconazole—Nausea—Alitretinoin—peripheral nervous system neoplasm	6.83e-05	0.000338	CcSEcCtD
Itraconazole—Visual impairment—Epirubicin—peripheral nervous system neoplasm	6.82e-05	0.000337	CcSEcCtD
Itraconazole—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	6.81e-05	0.000337	CcSEcCtD
Itraconazole—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	6.7e-05	0.000331	CcSEcCtD
Itraconazole—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	6.69e-05	0.000331	CcSEcCtD
Itraconazole—Eye disorder—Epirubicin—peripheral nervous system neoplasm	6.61e-05	0.000327	CcSEcCtD
Itraconazole—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	6.61e-05	0.000327	CcSEcCtD
Itraconazole—Tinnitus—Epirubicin—peripheral nervous system neoplasm	6.6e-05	0.000326	CcSEcCtD
Itraconazole—Nausea—Vincristine—peripheral nervous system neoplasm	6.58e-05	0.000325	CcSEcCtD
Itraconazole—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	6.57e-05	0.000325	CcSEcCtD
Itraconazole—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	6.57e-05	0.000325	CcSEcCtD
Itraconazole—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	6.55e-05	0.000324	CcSEcCtD
Itraconazole—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	6.52e-05	0.000322	CcSEcCtD
Itraconazole—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	6.5e-05	0.000322	CcSEcCtD
Itraconazole—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	6.47e-05	0.00032	CcSEcCtD
Itraconazole—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	6.45e-05	0.000319	CcSEcCtD
Itraconazole—Asthenia—Etoposide—peripheral nervous system neoplasm	6.44e-05	0.000318	CcSEcCtD
Itraconazole—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	6.44e-05	0.000318	CcSEcCtD
Itraconazole—Angiopathy—Epirubicin—peripheral nervous system neoplasm	6.42e-05	0.000318	CcSEcCtD
Itraconazole—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	6.42e-05	0.000318	CcSEcCtD
Itraconazole—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	6.39e-05	0.000316	CcSEcCtD
Itraconazole—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	6.38e-05	0.000316	CcSEcCtD
Itraconazole—Chills—Epirubicin—peripheral nervous system neoplasm	6.35e-05	0.000314	CcSEcCtD
Itraconazole—Pruritus—Etoposide—peripheral nervous system neoplasm	6.35e-05	0.000314	CcSEcCtD
Itraconazole—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	6.32e-05	0.000313	CcSEcCtD
Itraconazole—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	6.31e-05	0.000312	CcSEcCtD
Itraconazole—Alopecia—Epirubicin—peripheral nervous system neoplasm	6.25e-05	0.000309	CcSEcCtD
Itraconazole—Vomiting—Cisplatin—peripheral nervous system neoplasm	6.23e-05	0.000308	CcSEcCtD
Itraconazole—Mental disorder—Epirubicin—peripheral nervous system neoplasm	6.2e-05	0.000307	CcSEcCtD
Itraconazole—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	6.19e-05	0.000306	CcSEcCtD
Itraconazole—Rash—Cisplatin—peripheral nervous system neoplasm	6.17e-05	0.000305	CcSEcCtD
Itraconazole—Dermatitis—Cisplatin—peripheral nervous system neoplasm	6.17e-05	0.000305	CcSEcCtD
Itraconazole—Malnutrition—Epirubicin—peripheral nervous system neoplasm	6.16e-05	0.000305	CcSEcCtD
Itraconazole—Diarrhoea—Etoposide—peripheral nervous system neoplasm	6.14e-05	0.000304	CcSEcCtD
Itraconazole—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	6.12e-05	0.000303	CcSEcCtD
Itraconazole—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	6.11e-05	0.000302	CcSEcCtD
Itraconazole—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	6.08e-05	0.000301	CcSEcCtD
Itraconazole—Flatulence—Epirubicin—peripheral nervous system neoplasm	6.07e-05	0.0003	CcSEcCtD
Itraconazole—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	6.03e-05	0.000299	CcSEcCtD
Itraconazole—Back pain—Epirubicin—peripheral nervous system neoplasm	5.96e-05	0.000295	CcSEcCtD
Itraconazole—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	5.94e-05	0.000294	CcSEcCtD
Itraconazole—Dizziness—Etoposide—peripheral nervous system neoplasm	5.93e-05	0.000293	CcSEcCtD
Itraconazole—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	5.92e-05	0.000293	CcSEcCtD
Itraconazole—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	5.9e-05	0.000292	CcSEcCtD
Itraconazole—Chills—Doxorubicin—peripheral nervous system neoplasm	5.88e-05	0.000291	CcSEcCtD
Itraconazole—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	5.85e-05	0.000289	CcSEcCtD
Itraconazole—Nausea—Cisplatin—peripheral nervous system neoplasm	5.82e-05	0.000288	CcSEcCtD
Itraconazole—Vision blurred—Epirubicin—peripheral nervous system neoplasm	5.81e-05	0.000287	CcSEcCtD
Itraconazole—Alopecia—Doxorubicin—peripheral nervous system neoplasm	5.79e-05	0.000286	CcSEcCtD
Itraconazole—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	5.74e-05	0.000284	CcSEcCtD
Itraconazole—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	5.72e-05	0.000283	CcSEcCtD
Itraconazole—Vomiting—Etoposide—peripheral nervous system neoplasm	5.7e-05	0.000282	CcSEcCtD
Itraconazole—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	5.7e-05	0.000282	CcSEcCtD
Itraconazole—Rash—Etoposide—peripheral nervous system neoplasm	5.66e-05	0.00028	CcSEcCtD
Itraconazole—Dermatitis—Etoposide—peripheral nervous system neoplasm	5.65e-05	0.00028	CcSEcCtD
Itraconazole—Headache—Etoposide—peripheral nervous system neoplasm	5.62e-05	0.000278	CcSEcCtD
Itraconazole—Flatulence—Doxorubicin—peripheral nervous system neoplasm	5.62e-05	0.000278	CcSEcCtD
Itraconazole—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	5.58e-05	0.000276	CcSEcCtD
Itraconazole—Malaise—Epirubicin—peripheral nervous system neoplasm	5.56e-05	0.000275	CcSEcCtD
Itraconazole—Vertigo—Epirubicin—peripheral nervous system neoplasm	5.54e-05	0.000274	CcSEcCtD
Itraconazole—Syncope—Epirubicin—peripheral nervous system neoplasm	5.53e-05	0.000273	CcSEcCtD
Itraconazole—Leukopenia—Epirubicin—peripheral nervous system neoplasm	5.51e-05	0.000273	CcSEcCtD
Itraconazole—Back pain—Doxorubicin—peripheral nervous system neoplasm	5.51e-05	0.000273	CcSEcCtD
Itraconazole—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	5.42e-05	0.000268	CcSEcCtD
Itraconazole—Cough—Epirubicin—peripheral nervous system neoplasm	5.38e-05	0.000266	CcSEcCtD
Itraconazole—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	5.37e-05	0.000266	CcSEcCtD
Itraconazole—Nausea—Etoposide—peripheral nervous system neoplasm	5.33e-05	0.000264	CcSEcCtD
Itraconazole—Hypertension—Epirubicin—peripheral nervous system neoplasm	5.32e-05	0.000263	CcSEcCtD
Itraconazole—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	5.29e-05	0.000262	CcSEcCtD
Itraconazole—Arthralgia—Epirubicin—peripheral nervous system neoplasm	5.25e-05	0.00026	CcSEcCtD
Itraconazole—Myalgia—Epirubicin—peripheral nervous system neoplasm	5.25e-05	0.00026	CcSEcCtD
Itraconazole—Chest pain—Epirubicin—peripheral nervous system neoplasm	5.25e-05	0.00026	CcSEcCtD
Itraconazole—Anxiety—Epirubicin—peripheral nervous system neoplasm	5.23e-05	0.000259	CcSEcCtD
Itraconazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	5.21e-05	0.000258	CcSEcCtD
Itraconazole—Discomfort—Epirubicin—peripheral nervous system neoplasm	5.18e-05	0.000256	CcSEcCtD
Itraconazole—Malaise—Doxorubicin—peripheral nervous system neoplasm	5.14e-05	0.000254	CcSEcCtD
Itraconazole—Vertigo—Doxorubicin—peripheral nervous system neoplasm	5.12e-05	0.000253	CcSEcCtD
Itraconazole—Syncope—Doxorubicin—peripheral nervous system neoplasm	5.11e-05	0.000253	CcSEcCtD
Itraconazole—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	5.1e-05	0.000252	CcSEcCtD
Itraconazole—Confusional state—Epirubicin—peripheral nervous system neoplasm	5.07e-05	0.000251	CcSEcCtD
Itraconazole—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	5.03e-05	0.000249	CcSEcCtD
Itraconazole—Oedema—Epirubicin—peripheral nervous system neoplasm	5.03e-05	0.000249	CcSEcCtD
Itraconazole—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	5.01e-05	0.000248	CcSEcCtD
Itraconazole—Infection—Epirubicin—peripheral nervous system neoplasm	5e-05	0.000247	CcSEcCtD
Itraconazole—Cough—Doxorubicin—peripheral nervous system neoplasm	4.97e-05	0.000246	CcSEcCtD
Itraconazole—Shock—Epirubicin—peripheral nervous system neoplasm	4.95e-05	0.000245	CcSEcCtD
Itraconazole—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	4.93e-05	0.000244	CcSEcCtD
Itraconazole—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	4.92e-05	0.000244	CcSEcCtD
Itraconazole—Hypertension—Doxorubicin—peripheral nervous system neoplasm	4.92e-05	0.000244	CcSEcCtD
Itraconazole—Tachycardia—Epirubicin—peripheral nervous system neoplasm	4.91e-05	0.000243	CcSEcCtD
Itraconazole—Skin disorder—Epirubicin—peripheral nervous system neoplasm	4.88e-05	0.000242	CcSEcCtD
Itraconazole—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	4.86e-05	0.000241	CcSEcCtD
Itraconazole—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	4.85e-05	0.00024	CcSEcCtD
Itraconazole—Chest pain—Doxorubicin—peripheral nervous system neoplasm	4.85e-05	0.00024	CcSEcCtD
Itraconazole—Myalgia—Doxorubicin—peripheral nervous system neoplasm	4.85e-05	0.00024	CcSEcCtD
Itraconazole—Anxiety—Doxorubicin—peripheral nervous system neoplasm	4.84e-05	0.000239	CcSEcCtD
Itraconazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	4.82e-05	0.000238	CcSEcCtD
Itraconazole—Discomfort—Doxorubicin—peripheral nervous system neoplasm	4.8e-05	0.000237	CcSEcCtD
Itraconazole—Anorexia—Epirubicin—peripheral nervous system neoplasm	4.79e-05	0.000237	CcSEcCtD
Itraconazole—Hypotension—Epirubicin—peripheral nervous system neoplasm	4.7e-05	0.000232	CcSEcCtD
Itraconazole—Confusional state—Doxorubicin—peripheral nervous system neoplasm	4.69e-05	0.000232	CcSEcCtD
Itraconazole—Oedema—Doxorubicin—peripheral nervous system neoplasm	4.65e-05	0.00023	CcSEcCtD
Itraconazole—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	4.65e-05	0.00023	CcSEcCtD
Itraconazole—Infection—Doxorubicin—peripheral nervous system neoplasm	4.62e-05	0.000229	CcSEcCtD
Itraconazole—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	4.58e-05	0.000227	CcSEcCtD
Itraconazole—Shock—Doxorubicin—peripheral nervous system neoplasm	4.58e-05	0.000226	CcSEcCtD
Itraconazole—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	4.56e-05	0.000226	CcSEcCtD
Itraconazole—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	4.56e-05	0.000225	CcSEcCtD
Itraconazole—Insomnia—Epirubicin—peripheral nervous system neoplasm	4.55e-05	0.000225	CcSEcCtD
Itraconazole—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	4.54e-05	0.000225	CcSEcCtD
Itraconazole—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	4.52e-05	0.000224	CcSEcCtD
Itraconazole—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	4.52e-05	0.000223	CcSEcCtD
Itraconazole—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	4.5e-05	0.000223	CcSEcCtD
Itraconazole—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	4.48e-05	0.000222	CcSEcCtD
Itraconazole—Somnolence—Epirubicin—peripheral nervous system neoplasm	4.47e-05	0.000221	CcSEcCtD
Itraconazole—Anorexia—Doxorubicin—peripheral nervous system neoplasm	4.43e-05	0.000219	CcSEcCtD
Itraconazole—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	4.43e-05	0.000219	CcSEcCtD
Itraconazole—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	4.37e-05	0.000216	CcSEcCtD
Itraconazole—Hypotension—Doxorubicin—peripheral nervous system neoplasm	4.35e-05	0.000215	CcSEcCtD
Itraconazole—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	4.34e-05	0.000215	CcSEcCtD
Itraconazole—Fatigue—Epirubicin—peripheral nervous system neoplasm	4.34e-05	0.000214	CcSEcCtD
Itraconazole—Pain—Epirubicin—peripheral nervous system neoplasm	4.3e-05	0.000213	CcSEcCtD
Itraconazole—Constipation—Epirubicin—peripheral nervous system neoplasm	4.3e-05	0.000213	CcSEcCtD
Itraconazole—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	4.24e-05	0.00021	CcSEcCtD
Itraconazole—Insomnia—Doxorubicin—peripheral nervous system neoplasm	4.21e-05	0.000208	CcSEcCtD
Itraconazole—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	4.18e-05	0.000207	CcSEcCtD
Itraconazole—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	4.15e-05	0.000205	CcSEcCtD
Itraconazole—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	4.14e-05	0.000205	CcSEcCtD
Itraconazole—Somnolence—Doxorubicin—peripheral nervous system neoplasm	4.14e-05	0.000205	CcSEcCtD
Itraconazole—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	4.11e-05	0.000203	CcSEcCtD
Itraconazole—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	4.1e-05	0.000203	CcSEcCtD
Itraconazole—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	4.04e-05	0.0002	CcSEcCtD
Itraconazole—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	4.02e-05	0.000199	CcSEcCtD
Itraconazole—Fatigue—Doxorubicin—peripheral nervous system neoplasm	4.01e-05	0.000198	CcSEcCtD
Itraconazole—Urticaria—Epirubicin—peripheral nervous system neoplasm	3.99e-05	0.000198	CcSEcCtD
Itraconazole—Constipation—Doxorubicin—peripheral nervous system neoplasm	3.98e-05	0.000197	CcSEcCtD
Itraconazole—Pain—Doxorubicin—peripheral nervous system neoplasm	3.98e-05	0.000197	CcSEcCtD
Itraconazole—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	3.97e-05	0.000197	CcSEcCtD
Itraconazole—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	3.97e-05	0.000197	CcSEcCtD
Itraconazole—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	3.83e-05	0.00019	CcSEcCtD
Itraconazole—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	3.8e-05	0.000188	CcSEcCtD
Itraconazole—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	3.7e-05	0.000183	CcSEcCtD
Itraconazole—Urticaria—Doxorubicin—peripheral nervous system neoplasm	3.7e-05	0.000183	CcSEcCtD
Itraconazole—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	3.68e-05	0.000182	CcSEcCtD
Itraconazole—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	3.68e-05	0.000182	CcSEcCtD
Itraconazole—Asthenia—Epirubicin—peripheral nervous system neoplasm	3.61e-05	0.000178	CcSEcCtD
Itraconazole—Pruritus—Epirubicin—peripheral nervous system neoplasm	3.56e-05	0.000176	CcSEcCtD
Itraconazole—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	3.44e-05	0.00017	CcSEcCtD
Itraconazole—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	3.43e-05	0.00017	CcSEcCtD
Itraconazole—Asthenia—Doxorubicin—peripheral nervous system neoplasm	3.34e-05	0.000165	CcSEcCtD
Itraconazole—Dizziness—Epirubicin—peripheral nervous system neoplasm	3.33e-05	0.000165	CcSEcCtD
Itraconazole—Pruritus—Doxorubicin—peripheral nervous system neoplasm	3.29e-05	0.000163	CcSEcCtD
Itraconazole—Vomiting—Epirubicin—peripheral nervous system neoplasm	3.2e-05	0.000158	CcSEcCtD
Itraconazole—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	3.18e-05	0.000158	CcSEcCtD
Itraconazole—Rash—Epirubicin—peripheral nervous system neoplasm	3.17e-05	0.000157	CcSEcCtD
Itraconazole—Dermatitis—Epirubicin—peripheral nervous system neoplasm	3.17e-05	0.000157	CcSEcCtD
Itraconazole—Headache—Epirubicin—peripheral nervous system neoplasm	3.15e-05	0.000156	CcSEcCtD
Itraconazole—Dizziness—Doxorubicin—peripheral nervous system neoplasm	3.08e-05	0.000152	CcSEcCtD
Itraconazole—Nausea—Epirubicin—peripheral nervous system neoplasm	2.99e-05	0.000148	CcSEcCtD
Itraconazole—Vomiting—Doxorubicin—peripheral nervous system neoplasm	2.96e-05	0.000146	CcSEcCtD
Itraconazole—Rash—Doxorubicin—peripheral nervous system neoplasm	2.93e-05	0.000145	CcSEcCtD
Itraconazole—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	2.93e-05	0.000145	CcSEcCtD
Itraconazole—Headache—Doxorubicin—peripheral nervous system neoplasm	2.91e-05	0.000144	CcSEcCtD
Itraconazole—Nausea—Doxorubicin—peripheral nervous system neoplasm	2.76e-05	0.000137	CcSEcCtD
